Читать книгу Hypopharyngeal Cancer - Группа авторов - Страница 26

1Torre LA, Bray F, Siegel RL, et al: Global cancer statistics 2012. CA Cancer J Clin 2015; 65: 87–108.

2Sinard EP, Torre LA, Jemal A: International trends in head and neck cancer incidence differences by country, sex and anatomic site. Oral Oncol 2014; 50: 387–403.

3Gupta B, Johnson NW, Kumar N: Global epidemiology of head and neck cancers: a continuing challenge. Oncology 2016; 91: 13–23.

4Alkire BC, Bergmark RW, Chambers K, et al: Head and neck cancer in South Asia: macroeconomic consequences and the role of the head and neck surgeon. Head Neck 2016; 38: 1242–1247.

5Bien S, Kaminski B, Zyika S, et al: Evolution of the epidemiology and clinical characteristics of larynx and hypopharynx carcinoma in Poland from 1991 to 2001. Eur Arch Otorhinolaryngol 2008; 265(supp 1):S39–S46.

6Sankaranarayanan R, Massuyer E, Swaminathan R, et al: Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 1996; 18: 4779–4786.

7Pracy P, Loughran S, Good J, et al: Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130(suppl S2):S104–S110.

8Hoffman HT, Karnell LH, Shah JP, et al: Hypopharyngeal cancer patient evaluation. Laryngoscope 1997; 107: 1005–1017.

9Takes RP, Strojan P, Silver CE, et al: Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 2012; 34: 270–281.

10Ferlay J, Steliarorva-Foucher E, Lortet-Tieulent J, et al: Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374–1403.

11Perdomo S, Roa GM, Brennan P, et al: Head and neck cancer burden and prevention measures in Central and South America. Cancer Epidemiol 2016; 115:S43–S52.

12Aikire BC, Bergmark RW, Chambers K, et al: Head and neck cancer in South Asia: macroeconomics consequences and the role of the head and neck surgeon. Head Neck 2016; 38: 1242–1247.

13Ferlay J, Soerjomataram I, Ervik M, et al: GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide. IACR CancerBase No 11. Lyon, International Agency for Research on Cancer, 2013. http://globocan.iarc.fr.

14Dandekar M, Tuljapurkar V, Dhar H, et al: Head and neck cancers in India. J Surg Oncol 2017; 115: 555–563.

15Shield KD, Ferley J, Jemal A, et al: The Global Incidence of lip, oral cavity and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017; 67: 51–64.

16Farlay J, Soerjomataram I, Dikshit R, et al: Cancer incidence and mortality worldwide: sources, methods and major patterns in Globocan 2012. Int J Can 2015; 136:E359–E386.

17National Cancer Intelligence Network, Oxford Cancer Intelligence Unit: Profile of Head and Neck Cancers in England; Incidence, Mortality and Survival, 1990–2006.

18Louie KS, Mehenna H, Sasieni P: Trends in head and neck cancers in England from 1995 to 2011 and projected up to 2025. Oral Oncol 2015; 51: 341–348.

19Braakhuis BJ, Leeman CR, Viisser O: Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 2014; 50: 670–675.

20Blomberg M, Nielsen A, Munk C, et al: Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer 2011; 129: 733–741.

21Chiang CJ, Lo WC, Yang YW, et al: Incidence and survival of adult cancer patients in Taiwan, 2002 – 2012. J Formosan Med Assoc 2016; 115: 1076–1088.

22Hsu WL, Yu KJ, Chiang CJ, et al: Head and neck incidence trends in Taiwan, 1980–2014. Int J Head Neck Sci 2017; 1: 180–189.

23Shin A, Jung YS, Jung KW, et al: Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data. Laryngoscope 2013; 123:E30–E37.

24National Centre for Disease Informatics and Research, National Cancer Registry Programme: Three Year Report of Population Based Cancer Registries 2012–2014. Report of 27 PBCRs in India. http://www.ncrpindia.prg/ALL_NCRP_REPORTS/PBCR_REPORT_2012_2014_index.htm (viewed January 14, 2018).

25Mishra A, Meherotra R: Head and neck cancer: global burden and regional trends in India. Asian Pacific J Cancer Prev 2014; 15: 537–550.

26Ligier K, Belot A, Launoy G, et al.; network Francim: Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 2011; 47: 302–307.

27Lefebvre JL, Adenis L, Joveniaux A, et al: [Hypopharyngeal cancer in Northern region and Pas-de-Calais. Epidemiological factors]. Acta Chir Belg 1990; 90: 123–128.

28de Souza DL, Perez MM, Curado MP: Gender differences in the incidence of laryngeal and hypopharyngeal cancers in Spain. Cancer Epidemiol 2011; 35: 328–333.

29de Souza DL, Perez MM, Curado MP: Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol 2011; 35: 510–514.

30Associazione Italiana Registri Tumori (AIRTUM): Cancer in Italy, Version 2.0 Italian Association of Cancer Registries. http://www.registri-tumori.it (accessed November 18, 2017).

31Guntinas-Lichius O, Wendt T, Buentzel J, et al: Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 2010; 136: 55.

32American Cancer Society. Laryngeal and hypopharyngeal cancer. 2017. http://www.cancer.org/acs/groups/cid/documents/webcontent/003108-pdf.pdf.

33Eskander A, Mifsud M, Irish J, et al: Overview of surgery for laryngeal and hypopharyngeal cancer in Ontario, 2003–2010. Head Neck 2017; 37: 1559–1567.

34Kuo P, Chen MM, Decker RH, et al: Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope 2014; 124: 2064–2069.

35El Bedoui S, Lefebvre JL: Chapter 34 Management of Larynx and Hypopharyngeal Cancer in Otolaryngology Head and Neck Surgery, ed 2, 2017. http://emedicine360.com/Jaypee Brothers Medical Publishers Pvt. Ltd.

36Tangjaturonrasme N, Vatanasapt P, Bychkov A: Epidemiology of head and neck cancer in Thailand. Asia Pac J Clin Oncol 2018; 14: 16–22.

37Bhattacharjee A, Chakraborty A, Purkaystha P: Prevalence of head and neck cancers in the North East – an institutional study. Indian J Otolaryngol Head Neck Surg 2006; 58: 15–19.

38Anantharaman D, Marron M, Lagiou P, et al: Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011; 47: 725–731.

39Roswall N, Weiderpass E: Alcohol as a risk factor for cancer; existing evidence in a global perspective. J Prev Med Pub Health 2015; 48: 1–9.

40Lubin JH, Muscat J, Gaudet MM, et al: An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, and larynx in pooled data from 15 case-control studies. Cancer Causes Control 2011; 22: 1217–1231.

41Menville G, Luce D, Goldberg P, et al: Smoking, alcohol drinking and cancer risk in various sites of the larynx and hypopharynx. A case-control study in France. Eur J Cancer Prev 2004; 13: 165–172.

42Dickshit RP, Boffetta P, Bouchardy C, et al: Lifestyle habits as prognostic factors in survival of laryngeal and hypopharyngeal cancer: a multicentric European study. Int J Can 2005; 117: 992–995.

43Kuh D, Ben-Shlomo Y, Lynch J, et al: Life course epidemiology. J Epidemiol Community Health 2003; 57: 778–783.

44Lee CH, Lee K W, Fang FM, et al: The use of tobacco-free betel-quid in conjunction with alcohol/tobacco impacts early-onset age and carcinoma distribution for upper aerodigestive tract cancer. J Oral Pathol Med 2011; 40: 684–692.

45Boffetta P, Richiardi L, Berrino F, et al: Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 2003; 14: 203–212.

46Berrino F, Richiardi L, Boffetta P, et al: Occupation and larynx and hypopharynx: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 2003; 14: 212–223.

47Menville G, Luce D, Goldberg P, Leclerc A: Smoking, alcohol drinking, occupational exposure and social inequalities in hypopharyngeal and laryngeal cancer. Int J Epidemiol 2004; 33: 799–806.

48Mishra A, Meherotra R: Head and neck cancer: global burden and regional trends in India. Asian Pacific J Cancer Prev 2014; 15: 537–550.

49Sapkota A, Gajalakshmi V, Jetly DH, et al: Smokeless tobacco and increased risk of hypopharyngeal and laryngeal cancers: a multicentric case-control study in India. Int J Can 2007; 121: 1793–1798.

50Marron M, Boffetta P, Zhang ZF, et al: Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 2010; 39: 182–196.

51Lee KW, Kuo WR, Tsai SM, et al: Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int J Can 2005; 117: 831–836.

52Gupta PC, Ray CS: Epidemiology of betel quid usage. Ann Acad Med Singapore 2004; 33(suppl): 31S–36S.

53Secretan B, Straif K, Bann R, et al: A review of human carcinogens – part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 1033–1034.

54IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 100E (2012). http://monographs.iarc.fr/ENG/Monographs/vol100E/.

55Chen YJ, Chang JT, Liao CT, et al: Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99: 1507–1514.

56Jayalekshmi PA, Nandakumar A, Akiba S, et al: Association of tobacco use and alcohol drinking with laryngeal and hypopharyngeal cancer risks among men in Karunagappally, Kerela, India – Karunagappally cohort study. PLoS One 2013; 8:e73716.

57Anantharaman D, Marron M, Lagiou P, et al: Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011; 47: 725–731.

58Global Status Report on Alcohol and Health, 2014. http://www.who.int/substance_abuse/publications/global_alcohol_report/en/on.

59Znaor T, Vucemilo L, Kulis T, Znaor A: Incidence and mortality trends of head and neck cancer in Croatia in the period 1988–2008. Acta Oto-Laryngologica 2013; 133: 305–312.

60Maso LG, Tprelli N, Biancotto E, et al: Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur J Epidemiol 2016; 31: 385–393.

61Yokoyama A, Omori T, Yokoyama T: Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for preventing and screening for cancer in the upper aerodigestive tract in Eastern Asians. Keio J Med 2010; 59: 115–130.

62Seitz HK, Stickel F: Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007; 7: 599–612.

63Avincsal MO, Shinomiya H, Teshima M, et al: Impact of alcohol dehydrogenase-aldehyde dehydrogenase polymorphism on clinical outcome in patients with hypopharyngeal cancer. Head and Neck 2018; 40: 770–777.

64Heck JE, Sapkota A, Vendham HG, et al: Dietary risk factors for hypopharyngeal cancer in India. Cancer Causes Control 2008; 19: 1329–1337.

65Bakshi SS: Plummer Vinson Syndrome – is it common in males? Arq Gastroenterol 2015; 52: 250–252.

66Chisholm M: The association between webs, iron and post-cricoid carcinoma. Postgraduate Med J 1974; 50: 215–219.

67Jacobs A: Post-cricoid carcinoma: regional incidence in England and Wales. Br Med J 1963; 2: 1373–1375.

68Goel A, Bakshi SS, Soni N, Chhavi N: Iron deficiency anaemia and Plummer-Vinson syndrome: current insights. J Bllod Med 2017; 8: 175–184.

69Lydiatt WM, Patel SG, O’Sullivan B, et al: Head and neck cancers – major changes in the American Joint Committee on Cancer eight edition cancer staging manual. CA Cancer J Clin 2017; 67: 122–137.

70Wilson DD, Crandley EF, Sim A, et al: Prognostic significance of p16 and its relationship with human papillomavirus in pharyngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2014; 140: 647–653.

71Westra WH: The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist. Semin Diag Pathol 2015; 32: 42–53.

72Dalianis T, Grun N, Koch J, et al: Human papillomavirus DNA and p16(INK4a) and in relation to clinical outcome, in Stockholm, Sweden. Oral Oncol 2015; 51: 857–861.

73Mesham J, Wang PC, Chin R, et al: Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx. Am J Otolaryngol 2017; 38: 31–37.

74Shaughessey JN, Farghaly H, Wilson L, et al: HPV: a factor in organ preservation for locally advanced larynx and hypopharynx cancer? Am J Otolaryngol 2014; 35: 19–24.

75Joo YH, Lee YS, Cho KJ, et al: Characteristics and prognostic implications of high-risk HPV-associated hypopharyngeal cancers. PLoS One 2013; 8:e78718.

76Bishop JA, Lewis JS, Rocco JW, Faquin WC: HPV-related squamous cell carcinoma of the head and neck: an update on testing in routine pathology practice. Sem Diag Pathol 2015; 32: 344–351.

77Van der Putten L, de Bree R, Kuik DJ, et al: Hypopharyngeal carcinoma after radiation for tuberculosis: radiation-induced carcinoma. Oral Oncol 2010; 46: 672–677.

78Nigam A, Campbell JB, Das Gupta AR: Radiation induced tumours of the pharynx – can they be avoided? J Laryngol Otol 1990; 104: 129–130.

79Toda K, Shibuya H, Hayashi K, Ayukawa F: Radiation-induced cancer after radiotherapy for non-Hodgkin’s lymphoma of the head and neck: a retrospective study. Radiation Oncol (BioMed Central) 2009; 4: 21.

80Sturgis EM, Cinciripini PM: Trends in head and neck cancer incidence in relation to smoking prevalence. Cancer 2007; 110: 1429–1435.

81Anantharaman D, Marron M, Lagiou P, et al: Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer. Oral Oncol 2011; 47: 725–731.

82Colditz GA, Wolin KY, Gehlert S: Applying what we know to accelerate cancer prevention. Sci Transl Med 2012; 4: 127rv4.

83WHO Global Report on Trends in Tobacco Smoking 2000–2025. http://www.who.int/tobacco/publications/surveillance/reportontrendstobaccosmoking/en/index1.html (viewed December 10, 2017).

84WHO Global Strategy to Reduce the Harmful Use of Alcohol. http://www.who.int/substance_abuse/publications/global_strategy_reduce_harmful_use_alcohol/en/.

85Perdomo S, Roa GM, Brennan P, Forman D: Head and neck cancer burden and preventive measures in Central and South America. Cancer Epidemiol 2016; 44(suppl 1):S43–S52.

86Jegu J, Binder-Foucard F, Borel C, Velten M: Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 2013; 49: 9–14.

87Gandhi AK, Kumar P, Bhandari M, et al: Burden of preventable cancers in India: time to strike the cancer epidemic. J Egypt Natl Canc Inst 2017; 29: 11–18.

Patrick J. Bradley, MBA FRCS

Department of Otolaryngology, Head and Neck Surgery

Nottingham University Hospital NHS Trust, Queens Medical Centre Campus

Derby Road, Nottingham NG7 2UH (UK)

E-Mail pjbradley@zoo.co.uk